Tumor regression in c-DLL1 treated mice appears to be T-cell mediated, since c-DLL1 treatment had no effect on tumor growth in Rag1−/− recipients or in mice treated with anti-CD8 antibody (16). This evidence concerns the gene RAG1 and neoplasm.